Itamar Medical Highlights New WatchPATTM Scoring Guidelines Based on the COMPASS(1) Study Results from Johns Hopkins Sleep Investigators at SLEEP 2018

Evidence-based guidelines based on a large-scale sleep apnea study demonstrating
WatchPAT’s efficiency and accuracy compared to standard diagnostic alternatives

CAESAREA, Israel, May 30, 2018 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (TASE:ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for cardiology and sleep related breathing disorders, today announced plans to unveil the WatchPAT Scoring Guidelines, a streamlined approach for reviewing and editing WatchPAT data that integrates automated scoring with visual oversight. Researchers at Johns Hopkins Sleep Disorder Center developed the evidence-based guidelines, which will be presented June 5, 2018 at a lunch symposium hosted by Itamar Medical at SLEEP 2018, the 32nd Annual Meeting of the Associated Professional Sleep Societies (APSS). The meeting is taking place in Baltimore June 2 – 6. Latest surveys estimate that up to 1 billion patients around the world may be suffering from sleep apnea and over 80% of them are undiagnosed.